[Nipah and Hendra virus infectious diseases]

Nihon Rinsho. 2016 Dec;74(12):1973-1978.
[Article in Japanese]

Abstract

Nipah and Hendra virus were first identified in mid 1990s in Australia and Malaysia, caus- ing epidemics with high mortality rate in affected animals and humans. Since their first emer- gence, they continued to re-emerge in Australia and South East Asia almost every year. Nipah and Hendra virus were classified in the new genus Henipavirus because of their un- common features amongst Paramyxoviridae. Henipaviruses are zoonotic paramyxoviruses with a broad tropism, and cause severe acute respiratory disease and encephalitis. Their high virulence and wide host range make them to be given Biosecurity Level 4 status. This review summarizes details of Henipavirus emergence, reservoir hosts and pathology, and introduce recent progress in vaccines and antivirals.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Henipavirus Infections* / drug therapy
  • Henipavirus Infections* / prevention & control
  • Viral Vaccines / therapeutic use

Substances

  • Antiviral Agents
  • Viral Vaccines